Abstract
The immunogenicity and clinical safety of a local live attenuated canine adenovirus-1 vaccine (CAV-1) were evaluated in experimentally vaccinated native breed 3-4 months puppies. All vaccinated puppies did not show any abnormalities post-vaccination. Studying the blood picture revealed no changes in RBCs and haemoglobin values while there was an increase in the levels of total WBCs count, lymphocyte %, total serum protein and serum globulin. Liver and kidney function tests results were found to be within the normal values. These findings ensure vaccine safety. On the other side, the serum neutralization test was carried out on sera of vaccinated puppies and showed that these animals exhibited good levels of specific CAV-1 serum neutralizing antibodies able to protect them against virus infection. So, it could be said that the local CAV-1 vaccine is immunogenic vaccine suitable for dog protection against infectious canine hepatitis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
